ArticleBMJ open2023

Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease.

Oghenekome Gbinigie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.